352698 <common-name>4-[(4-chlorophenyl)methoxy]-n-[(e)-[1-phenyl-3-(4-propoxyphenyl)pyrazol-4-yl]methylideneamino]benzamide</common-name> <description>4-[(4-chlorophenyl)methoxy]-n-[(e)-[1-phenyl-3-(4-propoxyphenyl)pyrazol-4-yl]methylideneamino]benzamide is a chemical compound with the formula C33H29ClN4O3. With an average molecular weight of 565.10 g/mol, 4-[(4-chlorophenyl)methoxy]-n-[(e)-[1-phenyl-3-(4-propoxyphenyl)pyrazol-4-yl]methylideneamino]benzamide is a heavy molecule.</description> <cas>881664-80-8</cas> <pubchem-id>51061061</pubchem-id> <chemical-formula>C33H29ClN4O3</chemical-formula> <weight>565.1</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T19:10:37Z</created-at> <updated-at type="dateTime">2026-08-31T19:10:37Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCCOC1=CC=C(C=C1)C2=NN(C=C2C=NNC(=O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)Cl)C5=CC=CC=C5</moldb-smiles> <moldb-formula>C33H29ClN4O3</moldb-formula> <moldb-inchi>InChI=1S/C33H29ClN4O3/c1-2-20-40-30-16-10-25(11-17-30)32-27(22-38(37-32)29-6-4-3-5-7-29)21-35-36-33(39)26-12-18-31(19-13-26)41-23-24-8-14-28(34)15-9-24/h3-19,21-22H,2,20,23H2,1H3,(H,36,39)/b35-21+</moldb-inchi> <moldb-inchikey>GWMOHUQYRIFKOF-XICOUIIWSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">564.1928185</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>7.4</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM348591</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>4-[(4-chlorophenyl)methoxy]-n-[(e)-[1-phenyl-3-(4-propoxyphenyl)pyrazol-4-yl]methylideneamino]benzamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Pyrazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0302983</sync-id> <structure-inchikey>GWMOHUQYRIFKOF-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40000000000000008800002100000000000000000000000400080000000000000000002000202300000000000002004000000000000000000810002000000000000000000400000000000000000000022000020000300000204000040000000000020010080000000000082000000800008080100008040000000000000000020004040020000800000000000000080800000000100000000000000000000000000000000000000000000084000002000000000090000000200040000000000000000000000000000000000000000400010004000000000000220000000000000000040000000001040000000000400000000080000000080000200000020</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAApAAAALQAAAIABBgBgAAAAAQMGAGAAAAAC AgYAYAAAAAICCAAoAAAAAwIGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZA KAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQHQCgAAAADAwdAKAAA AAMDBkBoAAAAAwMBBkAoAAAAAwQGAGgAAAADAwEHACgAAAADAwcAaAAAAAMC AQYAKAAAAAMECAAoAAAAAwIGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZA KAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBCAAoAAAAAwIGAGAAAAACAgZAKAAA AAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAAD AwERACAAAAABBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEG QGgAAAADAwEGQGgAAAADAwELAAEAAQIAAgMAAwQgBAVoDAUGaAwGB2gMBwho DAgJaAwHCiAKC2gMCwxoDAwNaAwNDmgMDg8gDxAoAhARIBESIBITKAISFCAU FWgMFRZoDBYXaAwXGGgMGBloDBcaIBobABscABwdaAwdHmgMHh9oDB8gaAwg IWgMHyIADCMgIyRoDCQlaAwlJmgMJidoDCcoaAwJBGgMDgpoDBkUaAwhHGgM KCNoDEIFAAAABgQJCAcGBQULCg4NDAYVFhcYGRQGHR4fICEcBiQlJicoIxcE AAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:50:25Z</structure-indexed-at> </compound>